This study looks at how safe and effective a medicine called Afimkibart is for people with Atopic Dermatitis (AD), a skin condition causing itchy and inflamed patches. Participants who were in past Afimkibart trials can join. The study will check if the medicine continues to work well over a long time and if it’s safe to take.
Key Points:
- Eligibility: You must have been part of the earlier study and shown improvement in your skin condition.
- Commitment: You need to be willing to follow the study rules, go through skin checks, and provide blood samples.
- Exclusions: You cannot join if you have other skin problems that might affect results or had severe allergic reactions before.
How understandable was the trial content above?
Hard to understand
Easy to understand